This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

MK-0633

Merck & Co., Inc.

Drug Names(s): MK-0633, setileuton

Description: MK-0633 is a once-daily 5-lipoxygenase inhibitor that inhibits 5-Lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid.


MK-0633 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug